The Department of Laboratory Medicine and Pathology announces the appointment of Diana Oramas-Mogrovejo to our faculty as an assistant professor effective December 19. She comes to us from the University of Alabama at Birmingham.

Oramas-Mogrovejo earned her medical degree at the University of Guayaquil, Facultad de Ciencias Médicas, Ecuador in 2011. In 2019, she completed her pathology residency at the University of Illinois at Chicago, where she also served as chief resident in her final year. The following year she was a selective surgical pathology fellow and in 2021 a thoracic pathology fellow at the University of Texas MD Anderson Medical Center in Houston.

Oramas-Mogrovejo served as a volunteer physician at two regional hospitals in Ecuador. She has completed observerships both at Baylor University Medical Center in Dallas and the Medical College of Wisconsin in Milwaukee.

Her research interests include mesothelioma of mediastinum, thymic neoplasms, and non-small cell lung cancer. She is editor of the pulmonary/thoracic section of Human Pathology Reports.

During her medical education at the Universidad de Guayaquil, Oramas-Mogrovejo received the Mención de Honor Award for her annual academic achievement every year. She is a member of the College of American Pathologists (CAP), the U.S. and Canadian Academy of Pathology (USCAP), the American Society of Clinical Pathology (ASCP), and the American Medical Association (AMA).

Oramas DM, Moran CA. Primary Rosai-Dorfman disease of the thymus and lung: A clinicopathological and immunohistochemical study of three cases. Pathol Res Pract. 2022 Jun;234:153917. doi: 10.1016/j.prp.2022.153917. Epub 2022 Apr 26.

Oramas DM, Zaleski MP, Moran CA. Sarcomatoid mesothelioma: A clinicopathological and immunohistochemical study of 64 cases. Int J Surg Pathol. 2021 Dec;29(8):820- 825. doi: 10.1177/10668969211014256.

Oramas DM, Alqaidy D, Moran CA. Primary pulmonary hyalinizing spindle cell tumor with Giant rosettes: A clinicopathological and immunohistochemical study of 2 cases. Ann Diagn Pathol. 2021 Apr;51:151706. doi: 10.1016/j.anndiagpath.2021.151706. Epub 2021 Jan 14.

Oramas DM, Moran CA. Major pathological response (tumor regression) in patients treated for non-small cell carcinoma of the lung: Is there a magic number in the histological sections to be evaluated? Adv Anat Pathol. 2021 Mar 1;28(2):67-71. doi: 10.1097/PAP.0000000000000292.